Evidence map›Paper›PMID 27229121›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2016

Identification of intestinal ion transport defects in microvillus inclusion disease.

Dmitri V Kravtsov, Md Kaimul Ahsan, Vandana Kumari, Sven C D van Ijzendoorn, Miguel Reyes-Mugica, Anoop Kumar, Tarunmeet Gujral, Pradeep K Dudeja, Nadia A Ameen

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Experimental physiology · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Dmitri V KravtsovDepartment of Pediatrics/Gastroenterology and Hepatology, Yale School of Medicine, New Haven, Connecticut;
Md Kaimul AhsanDepartment of Pediatrics/Gastroenterology and Hepatology, Yale School of Medicine, New Haven, Connecticut;
Vandana KumariDepartment of Pediatrics/Gastroenterology and Hepatology, Yale School of Medicine, New Haven, Connecticut;
Sven C D van IjzendoornDepartment of Cell Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;
Miguel Reyes-MugicaChildren's Hospital Pittsburgh of UPMC, Pittsburgh, Pennsylvania;
Anoop KumarDivision of Gastroenterology and Hepatology, Department of Medicine, University of Illinois and Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois; and.
Tarunmeet GujralDivision of Gastroenterology and Hepatology, Department of Medicine, University of Illinois and Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois; and.
Pradeep K DudejaDivision of Gastroenterology and Hepatology, Department of Medicine, University of Illinois and Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois; and.
Nadia A AmeenDepartment of Pediatrics/Gastroenterology and Hepatology, Yale School of Medicine, New Haven, Connecticut; Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, Connecticut nadia.ameen@yale.edu.
Yale University · USJesse Brown VA Medical Center · USChildren's Hospital of Pittsburgh · USUniversity of Groningen · NLUniversity of Illinois Chicago · US

Funding

Yale Liver CenterP30DK034989 · NIDDK · YALE UNIVERSITY · PI YASUKO IWAKIRI · 1986 to 2026
$31.1M
Glucocorticoid and SGK1 regulation of CFTR in the intestine: role in diarrheaR01DK077065 · NIDDK · YALE UNIVERSITY · PI AMEEN, NADIA A. · 2008 to 2024
$5.8M
Probiotics:Potential Therapeutic Roles in DiarrheaR01DK081858 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEJA, PRADEEP K · 2008 to 2017
$2.5M
NIDDK NIH HHS P30 DK034989NIDDK NIH HHS R01 DK077065NIDDK NIH HHS R01 DK081858
6 · The paper itself

Abstract

Loss of function mutations in the actin motor myosin Vb (Myo5b) lead to microvillus inclusion disease (MVID) and death in newborns and children. MVID results in secretory diarrhea, brush border (BB) defects, villus atrophy, and microvillus inclusions (MVIs) in enterocytes. How loss of Myo5b results in increased stool loss of chloride (Cl(-)) and sodium (Na(+)) is unknown. The present study used Myo5b loss-of-function human MVID intestine, polarized intestinal cell models of secretory crypt (T84) and villus resembling (CaCo2BBe, C2BBe) enterocytes lacking Myo5b in conjunction with immunofluorescence confocal stimulated emission depletion (gSTED) imaging, immunohistochemical staining, transmission electron microscopy, shRNA silencing, immunoblots, and electrophysiological approaches to examine the distribution, expression, and function of the major BB ion transporters NHE3 (Na(+)), CFTR (Cl(-)), and SLC26A3 (DRA) (Cl(-)/HCO3 (-)) that control intestinal fluid transport. We hypothesized that enterocyte maturation defects lead villus atrophy with immature secretory cryptlike enterocytes in the MVID epithelium. We investigated the role of Myo5b in enterocyte maturation. NHE3 and DRA localization and function were markedly reduced on the BB membrane of human MVID enterocytes and Myo5bKD C2BBe cells, while CFTR localization was preserved. Forskolin-stimulated CFTR ion transport in Myo5bKD T84 cells resembled that of control. Loss of Myo5b led to YAP1 nuclear retention, retarded enterocyte maturation, and a cryptlike phenotype. We conclude that preservation of functional CFTR in immature enterocytes, reduced functional expression of NHE3, and DRA contribute to Cl(-) and Na(+) stool loss in MVID diarrhea.

Indexed as

Adaptor Proteins, Signal TransducingCaco-2 CellsChloride-Bicarbonate AntiportersCystic Fibrosis Transmembrane Conductance RegulatorEnterocytesGene Expression RegulationHumansIon TransportJejunumMalabsorption SyndromesMembrane Transport ProteinsMicrovilliMucolipidosesMyosin Heavy ChainsMyosin Type VPhenotypeAdaptor Proteins, Signal TransducingCFTR protein, humanChloride-Bicarbonate AntiportersCystic Fibrosis Transmembrane Conductance RegulatorMembrane Transport ProteinsMYO5B protein, humanMyosin Heavy ChainsMyosin Type VPhosphoproteinsSLC26A3 protein, humanSLC9A3 protein, humanSodium-Hydrogen Exchanger 3Sodium-Hydrogen ExchangersSulfate TransportersTranscription FactorsYAP1 protein, humanYAP-Signaling Proteinsbrush borderCFTRMVIMVIDMyo5bNHE3

Identifiers

PMID27229121
PMCPMC4967175
OpenAlexW2406128333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.